Castle Biosciences Inc.

21.34
-0.34 (-1.57%)
At close: Mar 03, 2025, 3:59 PM
21.27
-0.33%
After-hours: Mar 03, 2025, 04:54 PM EST

Castle Biosciences Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 332.07M 219.79M 137.04M 94.08M 62.65M 51.87M 22.79M 13.75M
Cost of Revenue n/a 44.98M 32.01M 15.82M 9.69M 7.31M 5.3M 4.92M
Gross Profit 332.07M 174.81M 105.03M 78.26M 52.96M 44.55M 17.49M 8.83M
Operating Income 8.67M -67.98M -91.14M -40.08M -6.54M 4.71M -3.84M -10.9M
Interest Income 12.92M 10.62M 3.97M 68K 373K 312K 23.51K 26.18K
Pretax Income 21.56M -57.37M -68.9M -40.01M -10.2M 5.35M -6.36M -12.36M
Net Income 18.25M -57.47M -67.14M -31.29M -10.28M 5.28M -6.37M -12.37M
Selling & General & Admin 200.05M 180.15M 143M 86.74M 48.13M 29.84M 16.47M 15.26M
Research & Development 52.04M 53.62M 44.9M 29.65M 13.26M 7.38M 4.85M 4.47M
Other Expenses 71.31M 9.01M 8.27M 1.96M -1.88M -2.93M -272.42K 163.29K
Operating Expenses 323.4M 242.78M 196.17M 118.34M 59.51M 37.23M 21.32M 19.73M
Interest Expense 577K 11K 17K 1K 2.63M 4.57M 2.27M 1.65M
Selling & Marketing Expenses 123.47M 113.66M 86.61M n/a n/a n/a n/a n/a
Cost & Expenses 323.4M 287.76M 228.18M 134.16M 69.19M 44.54M 26.62M 24.65M
Income Tax 3.32M 101K -1.77M -8.72M 84K 72K 8.61K 9.73K
Shares Outstanding (Basic) 27.78M 26.8M 26.05M 25.14M 18.93M 8.58M 10.65M 9.78M
Shares Outstanding (Diluted) 29.25M 26.8M 26.05M 25.14M 18.93M 8.66M 10.65M 9.78M
EPS (Basic) 0.66 -2.14 -2.58 -1.24 -0.54 0.35 -0.6 -1.26
EPS (Diluted) 0.62 -2.14 -2.58 -1.24 -0.54 -0.21 -0.6 -1.26
EBITDA 38.14M -45.02M -58.34M -36.6M -7.09M 7.69M -3.76M -10.4M
Depreciation & Amortization 16M 12.33M 10.54M 3.41M 472K 358K 323.02K 310.82K